Dipna Pharmachem Ltd — Important, 26-11-2025: Company Update

Dipna Pharmachem disclosed financial results for the quarter and half-year, reporting net sales of 72.33 Cr. Net profit for the half-year significantly increased to 1.41 Cr, up from 0.34 Cr in the previous half-year, despite lower sales. The company utilized funds from a 11.84 Cr Rights Issue and received 18.98 Cr from a preferential issue of convertible warrants, representing 25% of the total consideration. These funds are allocated to working capital and general corporate purposes, with no reported deviations. The company also disclosed various related party transactions, including loans and commission expenses.